Shownotes
This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE
Episode Overview:
Pharmaceutical launches are among the most complex, high-stakes endeavors in all of healthcare, and the difference between winning and losing often comes down to whether the right intelligence reaches the right people at the right moment.
Jason Smith, CTO of AI and Analytics at Within3, has spent his career solving exactly that problem.
A three-time co-founder whose companies have raised over $100 million in venture capital, Jason built rMark Bio from scratch before its acquisition by Within3, where his AI platform now powers launch decisions for all of the top 20 pharmaceutical companies.
Join us as Jason discusses how Within3's Launch Intelligence platform unifies field insights, social signals, EHR data, and stakeholder engagement into one integrated layer, empowering pharma teams to move with clarity and confidence. Let's go!
Episode Highlights:
- Jason sold his house, packed his dog in a U-Haul, and drove from Seattle to Chicago to launch rMark Bio in 2015.
- Within3 analyzes over 10 billion data points, filtered into hyper-focused disease community landscapes for pharmaceutical decision-makers.
- Life sciences AI differs from general models because context matters: how an MSL communicates is entirely different from a general user's query.
- Social listening gives pharma companies real-time aggregate patient and HCP sentiment, replacing slow, one-to-one relationship-based feedback loops.
- Jason is an 18-year cancer survivor and American Cancer Society advisor, making him personally invested in faster, better therapeutics for patients.
About our Guest:
Jason Smith is CTO of AI & Analytics at Within3, where he leads the team behind the company’s most advanced AI capabilities serving life sciences organizations. Jason is a three-time co-founder who built Cryptocybernetics, GrayArea, and rMark Bio from inception to successful exit. He was later brought in as CEO of xSides to lead its sale. Over his career, his companies have raised more than $100 million in venture and strategic capital. In addition to Within3, Jason is a Venture Fellow at MATTER, Advisor to Capita3, and a recognized thought leader in AI and Healthcare with publications and speaking engagements at HIMSS, Reuters, and leading healthcare and pharmaceutical conferences.
Links Supporting This Episode:
